130 related articles for article (PubMed ID: 6925982)
1. Regional immunotherapy in resectable squamous cell lung carcinoma. Analysis of a randomized study.
Roeslin N; Lang JM; Morand G; Wihlm JM; Witz JP
Cancer Immunol Immunother; 1982; 13(3):174-5. PubMed ID: 6925982
[TBL] [Abstract][Full Text] [Related]
2. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
[TBL] [Abstract][Full Text] [Related]
3. Intrapleural BCG in operable lung cancer.
Lowe J; Iles PB; Shore DF; Langman MJ; Baldwin RW
Lancet; 1980 Jan; 1(8158):11-4. PubMed ID: 6101353
[TBL] [Abstract][Full Text] [Related]
4. Post-operative intrapleural BCG in lung cancer: a 5-year follow-up report.
Bakker W; Nijhuis-Heddes JM; van der Velde EA
Cancer Immunol Immunother; 1986; 22(2):155-9. PubMed ID: 3719595
[TBL] [Abstract][Full Text] [Related]
5. A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung. LCSG Protocol 771.
Gail MH
Chest; 1994 Dec; 106(6 Suppl):287S-292S. PubMed ID: 7988246
[TBL] [Abstract][Full Text] [Related]
6. Regional immunotherapy of lung cancer with intrapleural B.C.G.
McKneally MF; Maver C; Kausel HW
Lancet; 1976 Feb; 1(7956):377-9. PubMed ID: 55646
[TBL] [Abstract][Full Text] [Related]
7. Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.
Wright PW; Hill LD; Peterson AV; Pinkham R; Johnson L; Ivey T; Bernstein I; Bagley C; Anderson R
Cancer Treat Rep; 1978 Nov; 62(11):1671-5. PubMed ID: 215304
[TBL] [Abstract][Full Text] [Related]
8. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.
Hadźiev S; Mandulova P; Kavaklieva-Dimitrova J; Penev K; Spassova M; Madźarova S
Neoplasma; 1982; 29(1):93-110. PubMed ID: 6280082
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS).
Yamamura Y; Sakatani M; Ogura T; Azuma I
Cancer; 1979 Apr; 43(4):1314-9. PubMed ID: 221088
[TBL] [Abstract][Full Text] [Related]
10. [Significance of immunotherapy as an adjunct to surgical treatment in non-small cell carcinoma of the lung].
Fujisawa T
Gan To Kagaku Ryoho; 1985 Jan; 12(1):13-20. PubMed ID: 2981513
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.
Jansen HM; The TH; Orie NG
Thorax; 1980 Oct; 35(10):781-7. PubMed ID: 7466726
[TBL] [Abstract][Full Text] [Related]
12. Trial of BCG immunotherapy in the treatment of resectable sequamous cell carcinoma of the bronchus (stages I and II).
Pouillart P; Mathé G; Palangie T; Schwarzenberg L; Huguenin P; Morin P; Gautier H; Baron A
Recent Results Cancer Res; 1977; (62):151-5. PubMed ID: 341247
[No Abstract] [Full Text] [Related]
13. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
Warren SE; Crispen RG; Nika B
Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
[TBL] [Abstract][Full Text] [Related]
14. Effect of BCG cell-wall skeleton immunotherapy on the peripheral blood lymphocytes in patients with lung cancer after radiotherapy.
Nishikawa H; Yasaki S; Yoshimoto T; Sakatani M; Itoh M; Masuno T; Namba M; Ogura T; Hirao F; Azuma I; Yamamura Y
Gan; 1978 Dec; 69(6):819-24. PubMed ID: 750274
[TBL] [Abstract][Full Text] [Related]
15. [Immunotherapy with BCG-CWS (cell-wall skeleton) in patients with primary lung cancer (author's transl)].
Takano T; Morishita M; Yamamoto M; Yamagata K; Takada K
Nihon Kyobu Shikkan Gakkai Zasshi; 1977 Nov; 15(11):769-74. PubMed ID: 606901
[No Abstract] [Full Text] [Related]
16. A preliminary trial of a novel form of active immunotherapy in squamous cell carcinoma of the lung.
Lachmann PJ; Grant RM; Freedman LS; Sikora K; Bleehen NM
Br J Cancer; 1985 Mar; 51(3):415-7. PubMed ID: 3882114
[No Abstract] [Full Text] [Related]
17. New method of immunotherapy for lung cancer.
Holmes EC; Ramming KP; Mink J; Coulson WF; Morton DL
Lancet; 1977 Sep; 2(8038):586-7. PubMed ID: 71401
[No Abstract] [Full Text] [Related]
18. Postoperative intrapleural BCG in lung cancer: lack of efficacy and possible enhancement of tumour growth.
Bakker W; Nijhuis-Heddes JM; Wever AM; Brutel de la Rivière A; van der Velde EA; Dijkman JH
Thorax; 1981 Nov; 36(11):870-4. PubMed ID: 7330812
[TBL] [Abstract][Full Text] [Related]
19. Regional immunotherapy with intrapleural BCG for lung cancer.
McKneally MF; Maver C; Kausel HW; Alley RD
J Thorac Cardiovasc Surg; 1976 Sep; 72(3):333-8. PubMed ID: 785107
[TBL] [Abstract][Full Text] [Related]
20. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
